Cognition Therapeutics
Price & Volume
Stats
See moreOpen | $1.05 |
Previous Close | $1.06 |
Day Range | $1.02-$1.05 |
52W Range | $0.55-$2.67 |
Market Cap | $99.8M |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.17 |
News
See moreYahoo Finance • 2 months ago
Cognition Seures FDA Alignment For Pivotal Phase 3 Trial Of Zervimesine In DLB Psychosis
Yahoo Finance • 2 months ago
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
Yahoo Finance • 3 months ago
Cognition Therapeutics Participating in Upcoming Investor Conferences
Yahoo Finance • 4 months ago
NanoViricides to Participate at D. Boral Capital Global Conference in NYC
About
CEO | Ms. Lisa Ricciardi |
Address | 2500 Westchester Ave., Purchase, NY, United States, 10577 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |